L-Methyl Folate 0.8mg Tablet PCD Pharma Franchise Delhi

Name: Folyflit Tablet (L-Methyl Folate IP (0.8 mg))
Brand: Folyflit Tablet
Rating: 4.8 (150 reviews)

L-Methyl Folate 0.8mg Tablet Manufacturing Company Baddi

L-Methyl Folate 0.8mg Tablet Nutraceutical Franchise Pune

L-Methyl Folate 0.8mg Tablet Pharma Supplier Mumbai

L-Methyl Folate 0.8mg Tablet Export Company Chennai

L-Methyl Folate 0.8mg Tablet Franchise Opportunity Hyd

Home/Products /l-methyl-folate-ip-0-8-mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

L-Methyl Folate 0.8mg Tablet from Best Pharma Exporter

L-Methyl Folate 0.8mg Tablet by Top Pharma Company in India

L-Methyl Folate 0.8 mg Tablet – PCD Pharma Franchise Marketing Material

Folyflit Tablet in Nutraceutical Medicine Franchise

Folyflit Tablet

Composition : L-Methyl Folate IP (0.8 mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹490/-

Contact For Business Query

Folyflit Tablet contains L-Methyl Folate, the active and bioavailable form of folic acid (Vitamin B9). Unlike synthetic folic acid, L-Methyl Folate does not require enzymatic conversion by methylenetetrahydrofolate reductase (MTHFR) and is directly available for cellular use. This makes it especially beneficial for individuals with MTHFR polymorphisms or impaired folate metabolism. L-Methyl Folate plays a crucial role in DNA synthesis, red blood cell production, homocysteine metabolism, and neurotransmitter synthesis. It is commonly used in the prevention and treatment of folate deficiency, megaloblastic anemia, and as a nutritional supplement in pregnancy to prevent neural tube defects. Additionally, it serves as an adjunct in cardiovascular health and certain psychiatric conditions linked to folate deficiency.

About the Product

Folyflit is generally well tolerated. Mild side effects may include nausea, bloating, or gastrointestinal discomfort. Rarely, allergic reactions such as rash, itching, or swelling can occur. Very high doses may mask Vitamin B12 deficiency, so proper diagnosis is essential in megaloblastic anemia cases.

Folyflit Tablet is indicated for the prevention and treatment of folate deficiency, megaloblastic anemia, and as a prenatal supplement to prevent neural tube defects in developing fetuses. It is also used as adjunctive therapy in hyperhomocysteinemia, cardiovascular disorders, and in certain psychiatric conditions where folate metabolism support is beneficial.

Folyflit Tablet should be taken under medical guidance, especially in patients with anemia to confirm the underlying cause. It is safe for use during pregnancy and lactation at recommended doses. Individuals with Vitamin B12 deficiency should be supplemented accordingly to prevent neurological complications. Avoid self-medication in high doses without consulting a healthcare professional. Consistent use is necessary to achieve therapeutic benefits in deficiency states.

Store Folyflit Tablet in a cool, dry place below 30°C. Protect from direct sunlight and moisture. Keep the tablets in their original blister pack and out of reach of children. Do not use after the expiry date mentioned on the strip.